Search for: "TEVA USA, INC." Results 281 - 300 of 646
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Chicago Psychiatrist Who Received Consulting Fees (Now Called Kickbacks) While Prescribing Clozaril to Patients Sentenced to Nine Months in Federal Prison After Qui Tam Lawsuit Settlement
29 Mar 2016, 7:21 am by Green and Associates
Reinstein agreed to switch his patients to the generic version, but only after its manufacturers, Teva Pharmaceuticals USA Inc. and IVAX Pharmaceuticals LLC, agreed to pay him a consulting fee and finance a Clozapine research study performed by a Reinstein-affiliated entity. [read post]
California Attorneys Representing Licensed, Regulated And Other Professionals - http://greenandassociates.blogspot.com/
The novelty of “on sale inventions” under a confidentiality agreement with regards to an “on sale” invention: the US Supreme Court rules
31 Jan 2019, 8:32 am
TEVA Pharmaceuticals USA INC., et al.,  had the opportunity to interpret the Leahy-Smith America Invents Act (AIA) with respect to how this impacts on the issue of the novelty of an invention. [read post]
IPKat - http://ipkitten.blogspot.com/
Supreme Court: Secret Sales are Still Prior Art
22 Jan 2019, 8:28 am by Dennis Crouch
Teva Pharma USA (Supreme Court 2019) The Supreme Court has affirmed the Federal Circuit’s interpretation of the “on sale bar” — holding that “Congress did not alter the meaning of ‘on sale’ when it enacted the AIA. [read post]
Patently-O - http://patentlyo.com/patent
CAFC reverses ND Ill on indefiniteness point in Sonix case
5 Jan 2017, 10:14 am by Lawrence B. Ebert
USA, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Fenner v. Cellco: Judge Newman Speaks on Claim Construction
15 Feb 2015, 12:58 pm by Jason Rantanen
USA, Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court Holds Over Two Patent Cases, Considers Two More on Patent Eligibility
1 May 2023, 10:11 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. v. [read post]
Patently-O - https://patentlyo.com
Federal Circuit: Hardening the Line on Method-of-Treatment Claims
28 Mar 2019, 9:07 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. [read post]
Patently-O - http://patentlyo.com/patent
Judge Stark grants motion for summary judgment of invalidity for obviousness.
1 Apr 2014, 8:55 am by James L. Higgins
Teva Pharmaceuticals USA, Inc., et al., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Supreme Court Rules: Sale of Invention can Prevent Patenting
23 Jan 2019, 10:00 pm
Teva Pharmaceuticals USA Inc., No. 17-1229 (2019). [read post]
Filewrapper.com - http://www.filewrapper.com/
Live blog of orders and opinions with John Elwood and First Mondays (Update: Completed)
25 Jun 2018, 5:40 am by Andrew Hamm
Teva Pharmacueticals USA Inc. [read post]
SCOTUSblog - http://www.scotusblog.com/
The District of Delaware Adopts the Federal Circuit’s Factors in Rejecting Regulatory Bar in a Protective Order
30 Aug 2023, 6:09 am by Charles H. Chevalier and Michael V. Caracappa
Teva Pharmaceuticals USA, Inc., No. 18-3632, Judge Cathy L. [read post]
Employment Law Alert - http://www.employmentlawalert.com
The District of Delaware Adopts the Federal Circuit’s Factors in Rejecting Regulatory Bar in a Protective Order
30 Aug 2023, 6:09 am by Charles H. Chevalier and Michael V. Caracappa
Teva Pharmaceuticals USA, Inc., No. 18-3632, Judge Cathy L. [read post]
Real Property & Environmental Law Alert - http://www.rpelawalert.com/
The District of Delaware Adopts the Federal Circuit’s Factors in Rejecting Regulatory Bar in a Protective Order
30 Aug 2023, 6:09 am by Charles H. Chevalier and Michael V. Caracappa
Teva Pharmaceuticals USA, Inc., No. 18-3632, Judge Cathy L. [read post]
IP Law Alert - http://www.iplawalert.com
CAFC Finds Promise Not to Infringe Insufficient in ANDA Litigation
2 Oct 2013, 8:58 am by Gene Quinn
Teva Pharmaceuticals USA et al. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
VIAGRA Patent Decision Gives Rise to Dispute Over ANDA Approval, Concern About 180-Day Exclusivity Forfeiture; Court Rigidly Applies Patent Statute
24 Oct 2011, 1:39 pm by FDABlog HPM
District Court for the Eastern District of Virginia that Teva Pharmaceuticals USA, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Chief Judge Gregory M. Sleet: Markman Opinion
8 Nov 2010, 7:35 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Chief Justice Finds Generics’ Entry Into Drug Maker's Exclusive Market Does Not Pose Threat of Irreparable Harm
21 Apr 2014, 8:03 am by James M. Lennon
The case is Teva Pharmaceuticals USA Inc. et al. v. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
The saga of strict de novo review of patent claim construction comes to an end — U.S. Supreme Court tweaks the standard of appellate review
6 Feb 2015, 8:57 am by Martin Miller
Background Teva Pharmaceuticals USA, Inc. v. [read post]
Technology Law Source - http://www.technologylawsource.com/
First Dust Up Over Generic PROVIGIL 180-Day Exclusivity Quickly Put on Hold With TRO/PI Motion Withdrawal, But is Followed Up With a Second Lawsuit
5 Apr 2012, 1:41 pm by FDABlog HPM
(“Teva”) and Cephalon, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
"Motivation to combine" analyzed by CAFC in Dako v. Leica
5 Dec 2016, 2:27 pm by Lawrence B. Ebert
USA, Inc. v.Sandoz, Inc., 135 S. [read post]
IPBiz - http://ipbiz.blogspot.com/